Conference abstract
Lysyl oxidase propeptide (LOX-PP) inhibits oral cancer metastasis and tumor growth by interacting with stromal cell-derived factor 1 (SDF-1), syndecan-4 (SDC-4) and syndecan-1 (SDC-1)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The lysyl oxidase propeptide (LOX-PP) is derived from pro-lysyl oxidase (Pro-LOX) by extracellular biosynthetic proteolysis. LOX-PP inhibits oral cancer xenograft tumor growth and metastasis. Data indicate that LOX-PP inhibits distant metastasis of UMSCC2 oral carcinoma tumor xenograft by inhibiting shedding of SDC-1 and -4 ectodomains via down-regulating Stromal cell-derived factor 1 (SDF-1) activity. LOX-PP also binds both SDC1 and -4 and inhibits binding of FGFR1 to its ligand and the downstream signaling in non-metastatic oral cancer line SCC9. LOX-PP binds to SDC4 and inhibits SDC-4 oligomerization and FGFR1/FGF2/SDC-4 complex formation via SDC-4 to FGF2 binding in SCC9 cell line. We demonstrated that, LOX-PP promotes the formation of SDC-4/synectin/RhoGDI1/RhoG complex/ monomer. Therefore, dissociation of RhoG from RhoGDI1 is suppressed and eventually Rac-1 activation and cell proliferation inhibited in SCC9 cells. We also demonstrate that the uptake for LOX-PP is SDC-4 dependent macro-pinocytosis and SDC-1 regulates uptake/recycling of LOX-PP in both UMSCC2 and SCC9 cell lines.
Keywords
Subjects
Dentistry & Oral HealthAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOral Health and Dental Management
- SubjectDentistry & Oral Health
- BylineArticles whose byline prints “Gokhan Baris Ozdener”
